Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reproxalap Phase 2b in Dry Eye Disease
NCT03404115Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reproxalap in dry eye disease (DED), sponsored by Aldeyra Therapeutics. Started Jan 2018; status: completed.
02
Drugs
reproxalap
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03404115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03404115.